Alexandra Aaldijk

Alexandra Aaldijk is an active researcher specializing in endocrinology and metabolic disease mechanisms, with particular expertise in fibroblast growth factors (FGF19/FGF21) and the beta-klotho coreceptor system. Her work bridges molecular biology and clinical hepatology through analysis of human tissue samples and liver biopsies.

Her research portfolio demonstrates deep focus on metabolic regulation pathways, with significant contributions to understanding FGF signaling in liver disease. Key investigations include:

• Mechanistic studies of beta-klotho protein expression in healthy and diseased human tissues
• Pharmacological characterization of FGF19/FGF21 coreceptor functions
• Translational research connecting molecular pathways to MASLD/MASH pathophysiology

Analysis of her publication trends reveals consistent advancement in metabolic endocrinology, with growing emphasis on human tissue validation of molecular targets. Her 2023 review established foundational knowledge of FGF pharmacology, while the 2025 article demonstrates progression into clinical tissue analysis.

Research support appears active based on recent publications, though specific grant details aren't documented. Her collaborative network includes multiple co-authors across hepatic and metabolic research domains, suggesting integration within larger research consortia focused on metabolic diseases.

While no dedicated laboratory is specified, her tissue-based research methodology indicates access to clinical sample repositories and molecular analysis facilities through institutional collaborations. Her work trajectory shows progression from pharmacological review to original clinical tissue research within a two-year timeframe.